(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Therapy in cardiology has advanced enormously in recent years. This has resulted in the organization of many meetings and the publication of numerous books dedicated to examining the latest aspects of, for instance, pharmacolog ic, electrical and surgical treatment. However, only a few of these meetings and publications have attempted to present an overall review of all advances that have taken place in the field of therapy. In the last years the Spanish Society of Cardiology has shown a great interest in the continuous medical education in cardiology. The Society has organized various meetings and has published several books on the above-mentioned topics. Consequently, the Society has decided to publish this book, an update of the therapeutics in cardiology, of which a Spanish version is also available. World renowned experts and outstanding Spanish cardiologists were invited to review all aspects of therapy in cardiology. We would like to thank the Spanish Society of Cardiology and the Catalan Cardiac Society for the generous assistance they have given us during all stages of book preparation. We also would like to express our appreciation to all the authors for their valuable contributions. Their combined efforts enable us to put this volume in the hands of the reader.
Contents:
1. Severe Arrhythmias and Sudden Death.- 1.1 Introduction.- 1.2 Influence of circadian rhythm on the electrophysiological properties of the human heart.- 1.3 Sudden arrhythmic death - picture of the possible candidate.- 1.4 Sudden death in cardiomyopathies.- 1.5 Sudden death in the Wolff-Parkinson-White syndrome.- 1.6 Conclusions.- 2. The Pharmacological Treatment of Severe Arrhythmias.- 2.1 Introduction.- 2.2 Torsades de pointe.- 2.3 Non-invasive assessment of antiarrhythmic drugs.- 2.4 An electrophysiological approach to drug therapy of ventricular arrhythmias.- 2.5 Application of plasma level determinations to antiarrhythmic drug management.- 2.6 Amiodarone as drug of first choice in the prevention of sustained ventricular tachycardia (VT) and/or ventricular fibrillation (VF).- 2.7 Conclusions.- 3. The Surgical Treatment of the Arrhythmias.- 3.1 Introduction.- 3.2 The role of left stellectomy in the prevention of lethal arrhythmias.- 3.3 Surgical treatment of the cardiac arrhythmias.- 3.4 Early experience in endocardial fulguration for the treatment of ventricular tachycardia.- 3.5 The implantable cardioverter-defibrillator.- 3.6 Conclusions.- 4. Pacemakers.- 4.1 Introduction.- 4.2 Electrophysiological studies in patients with syncope of unknown cause.- 4.3 Tachylog P43 in the control of tachyarrhythmias.- 4.4 Control of the pacemaker patient.- 4.5 Conclusions.- 5. Arterial Hypertension.- 5.1 Introduction.- 5.2 The value of treatment in the prevention of hypertension complications.- 5.3 Use of ?-adrenergic blocking agents in arterial hypertension.- 5.4 Other antihypertensive drugs.- 5.5 Problems in the treatment of chronic primary arterial hypertension.- 5.6 Conclusions.- 6. Heart Failure.- 6.1 Introduction.- 6.2 Patients with heart failure and normal sinus rhythm: who should receive digitalis?.- 6.3 Vasodilators in the treatment of congestive heart failure.- 6.4 The new inotropic agents.- 6.5 Right ventricular failure in ischaemic heart disease.- 6.6 Conclusions.- 7. Heart-Lung Transplantation.- 7.1 Introduction.- 7.2 Transplantation of the heart and lungs.- 7.3 Heart transplantation.- 8. Valvulopathies.- 8.1 Introduction.- 8.2 Bioprosthesis versus mechanical devices.- 8.3 Conservative mitral valve surgery.- 8.4 Chronic valvular heart disease: timing of surgery.- 8.5 Diagnosis of prosthetic dysfunction by means of echocardiography and Doppler ultrasound.- 8.6 Conclusions.- 9. Surgical Correction of Tetralogy of Fallot: Mid-Term Results.- 9.1 Introduction.- 9.2 Mid-term postoperative cardiac catheterization studies after corrective surgery for tetralogy of Fallot.- 9.3 Mid- and long-term postoperative results of tetralogy of Fallot cases operated on in the Hospital Infantil, Ciudad Sanitaria 'Vall d'Hebron' (1971-1983).- 9.4 Cardiac dysrhythmias after surgical treatment of tetralogy of Fallot.- 9.5 Tetralogy of Fallot: present status of corrective surgery and midterm follow-up.- 10. Angina Pectoris (I).- 10.1 Introduction.- 10.2 Coronary reserve and angina therapy.- 10.3 Nitrates in the treatment of angina pectoris.- 10.4 Comparison of four calcium antagonists with placebo and propranolol.- 10.5 Pathophysiology of unstable angina pectoris: clinical, angiographic and therapeutic observations.- 10.6 Treatment of primary angina.- 10.7 Conclusions.- 11. Angina Pectoris (II): Instrumental Procedures.- 11.1 Introduction.- 11.2 Current status of coronary angioplasty in Spain.- 11.3 Coronary angioplasty: a new way to revascularization of the heart.- 11.4 Long-term results of coronary artery bypass graft surgery: experience of the Montreal Heart Institute.- 11.5 The Netherlands coronary surgery study (N.C.S.): coronary bypass surgery in patients with mild angina pectoris.- 11.6 Laser treatment of coronary artery disease.- 11.7 Conclusions.- 12. Myocardial Infarction (I).- 12.1 Introduction.- 12.2 Recanalization of coronary arteries by thrombolytic agents in acute myocardial infarction.- 12.3 Rupture of the free ventricular wall during the acute phase of myocardial infarction: diagnosis and treatment.- 12.4 Myocardial revascularization with acute myocardial infarction.- 12.5 Twenty-five years of Coronary Units: perspectives for the future.- 12.6 Thrombolysis in acute myocardial infarction.- 12.7 Conclusions.- 13. Myocardial Infarction (II): Primary and Secondary Prevention.- 13.1 Introduction.- 13.2 How, when and who to treat for dyslipemia.- 13.3 Prophylactic ?-blocking treatment after myocardial infarction.- 13.4 Criticism of long-term preventive treatment after myocardial infarction.- 13.5 Strategies for postinfarction treatment.- 13.6 Conclusions.- Index of Subjects.
PRODUCT DETAILS
Publisher: Springer
Publication date: October, 2011
Pages: 700
Weight: 1068g
Availability: Available
Subcategories: Cardiovascular Medicine
From the same series
Jean-Claude Tardif
Xander H T Wehrens
Johan H. C. Reiber
Raimund Erbel
M.P. Sambhi
Pedro Brugada
W. Bleifeld
Naranjan S. Dhalla
Bohuslav Ostadal
Ralph Shabetai
Jason X.-J. Yuan
Hein J.J. Wellens
R. C. Becker
C.H. Peels
Franz H. Messerli
Stephen M. Factor
Hiroyuki Suga
Hugo Ector
Brian E. Jaski
Seymour Glagov
Richard A. Walsh
Michiel J. Janse
Lloyd W. Klein
Thomas H Marwick
Ernst E. van der Wall
P.J. Walter
Ernst E. van der Wall
Ernst E. van der Wall
A-M. Salmasi
Ernst E. van der Wall
C.A. Nienaber
Andrea Natale
Guillem Pons-Llado
A-M. Salmasi
Albert de Roos
Michel Emile Safar
Vinzenz Hombach
R. Vos
J. Candell-Riera
Peter Hanrath
R.W. Stout
Johan H. C. Reiber
P.A.F.M. Doevendans
P.A.F.M. Doevendans
Jack Rychik
C.J. Preusse
Myrvin H. Ellestad
George D. Dangas
P.E. Vardas
Makoto Nagano
Thomas H Marwick
Thomas H Marwick
Ernst E. van der Wall
G.T. Meester
A.G. Herman
J.C. Tardif
P.J. Walter
Johan H. C. Reiber
Lloyd W. Klein
Robert L. Wilensky
Ernst E. van der Wall
Akira Matsumori
John F. Keaney Jr.
Bernard Swynghedauw
Juan Carlos Kaski
Franz H. Messerli
Keith L. March
Naranjan S. Dhalla
Juan Carlos Kaski
Zainul Abedin
Eric J Topol
A.V. Bruschke
J. Candell-Riera
Richard C. Becker
Ghassan Bkaily
Lionel H. Opie
P. Cummins
Bernard Swynghedauw
Geoffrey Burnstock
Nicholas Sperelakis
Mina Rajskina
A.A. Knowlton
Johan H. C. Reiber
Irene D. Turpie
J. A. E. Spaan
Ernst E. van der Wall
Masatsugu Hori
Bing Liem Liong
R. Fagard
M. Iwase
R. Stroobandt
A.V. Bruschke
David M. Mirvis
Franz H. Messerli
G. Assmann
Melvin Scheinman
J. Morganroth
J.W. de Jong
C. Tissa Kappagoda
M.B. Rosenbaum
H.V. Villareal
J. Morganroth
Ernst E. van der Wall
Naranjan S. Dhalla
J.R. Roelandt
M.P. Spencer
Henk Keurs
H. Mitchell Perry Jr.
C.T. Lancée
G.S. Wagner
H. Kesteloot
A.C. Arntzenius
Johan H. C. Reiber
W. Bleifeld
M.P. Spencer
A. Maseri
Michel Emile Safar
Henk Keurs
Willem H. Birkenhager
J.R. Roelandt
Naranjan S. Dhalla
H. Rijsterborgh
Marianne J. Legato
Naranjan S. Dhalla
H.E. Van Dam
M.P. Spencer
S. Chien
J.R. Roelandt
Hilbert J.Th. Thalen
Rafael Beyar
J.P.M Hamer
L.N. Bouman
Borys Surawicz
Douglas P. Zipes
C. Marchesi
Rafael Beyar
Nicholas Sperelakis
A. Alboni
Johan H. C. Reiber
Hein J.J. Wellens
Antonio Bayes de Luna
E. Aliot
J.V. Chapman
Michael R. Rosen
William H. Gaasch
Pawan K. Singal
Vinzenz Hombach
Robert Plonsey
H.L. Stone
J. Soler-Soler
Ernst E. van der Wall
Michel Emile Safar
J. Morganroth
Vinzenz Hombach
J.R. Roelandt
Richard S. Meltzer
Marvin A. Konstam
Hein J.J. Wellens
Naranjan S. Dhalla
Naranjan S. Dhalla
S.N. Willich
Johan H. C. Reiber
Ernst E. van der Wall
C.A. Nienaber
Elliot Rapaport
Naranjan S. Dhalla
Derek Yellon
Andrew Wechsler
John E. Tooke
Robert J. Siegel
Markus Schwaiger
J.W. de Jong
Henk Keurs
Steve M. Teague
Naranjan S. Dhalla
Nicholas Sperelakis
P.H. Heintzen
J. Morganroth
John B. Lombardini
Adam Schneeweiss
J.R. Roelandt
Naranjan S. Dhalla
Naranjan S. Dhalla
J.C. Chatham
Pim J. de Feyter
David W. Holt
Catherine A. Neill
J. Roelandt
A.P. Shepherd
Gastone Leonetti
Nico H.J. Pijls
K. Robinson
P.A.F.M. Doevendans
Douglas P. Zipes
Jose Marin-Garcia
Jonathan S. Steinberg
Francisco Villarreal
Dick Macdonald
Ragavendra R. Baliga
Dick Macdonald


















































































































































































































































